BeStock  
Stocks › Biotechnology › CRMD

CorMedix CRMD

US equityMarket cap rank #3658Biotechnology
$7.28 +$0.00 (0.00%)
Pre-market · Oct 8, 8:20 am ET · After hours $7.30 +0.28%
Open$7.27
Prev close$7.28
Day range$7.18 – $7.31
Volume833.1K
Market cap$567.43M
P/E (TTM)3.3
Dividend yield–

Earnings

Average move on report day±13.1%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+30.2%
Worst reaction-31.8%

Stock move on the day after each report

+6.4%2023/Q3-2.8%2023/Q4-5.2%2024/Q1+30.2%2024/Q2-22.5%2024/Q3-31.8%2024/Q4+23.6%2025/Q1-9.5%2025/Q2+2.1%2025/Q3-11.5%2025/Q4+5.7%2026/Q1+14.6%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q213 Aug 2026Pre Market±13.5%+14.65%Bigger than priced
2026/Q114 May 2026Pre Market±15.0%+5.73%Within range
2025/Q45 Mar 2026Pre Market±14.9%-11.52%Within range
2025/Q312 Nov 2025Pre Market±13.6%+2.06%Within range
2025/Q27 Aug 2025Pre Market±18.3%-9.54%Within range
2025/Q16 May 2025Pre Market±20.7%+23.59%Bigger than priced
2024/Q425 Mar 2025Pre Market±21.4%-31.85%Bigger than priced
2024/Q330 Oct 2024Pre Market±22.0%-22.51%Bigger than priced
2024/Q214 Aug 2024Pre Market±19.1%+30.16%Bigger than priced
2024/Q19 May 2024Pre Market±16.5%-5.17%Within range
2023/Q412 Mar 2024Pre Market±20.0%-2.84%Within range
2023/Q314 Nov 2023After Market±44.9%+6.39%Within range
2023/Q28 Aug 2023Pre Market±20.6%+7.94%Within range
2023/Q115 May 2023After Market±19.5%-13.40%Within range
2022/Q430 Mar 2023Pre Market±27.6%+13.11%Within range
2022/Q310 Nov 2022Pre Market±25.1%+9.19%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • DefenCath$66.12M 66.6%
  • Melinta Portfolio$28.22M 28.4%
  • Contract revenue$4.97M 5.0%

Latest reported quarter: Q2, ended Jun 2026

Revenue$99.31M+149.9% YoY
Operating profit$42.91M+119.6% YoY
Net profit$25.99M+31.1% YoY
Diluted EPS$0.29+3.6% YoY
Free cash flow$85.68M+185.9% YoY
Operating cash flow$86.24M

Revenue, last 8 quarters

$11.5MSep '24$31.2MDec '24$39.1MMar '25$39.7MJun '25$104.3MSep '25$128.6MDec '25$127.4MMar '26$99.3MJun '26

Net profit, last 8 quarters

$-2.8MSep '24$13.5MDec '24$20.6MMar '25$19.8MJun '25$108.6MSep '25$14.0MDec '25$38.6MMar '26$26.0MJun '26

Profitability & balance sheet

Gross margin82.6%
Operating margin47.5%
Net margin40.7%
Return on equity54.6%
Return on assets32.2%
Return on invested capital45.0%
Current ratio2.56
Liabilities / assets49.0%
Cash & investments$256.69M
Total debt$145.15M
Net cash (debt)$111.54M
Free cash flow / sales54.8%

Discussion

No comments yet — be the first to weigh in on CRMD.

Leave a comment

Scroll to Top